{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T17:40:20Z","timestamp":1718905220921},"reference-count":30,"publisher":"The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Turk J Med Sci"],"published-print":{"date-parts":[[2016]]},"DOI":"10.3906\/sag-1501-58","type":"journal-article","created":{"date-parts":[[2016,11,17]],"date-time":"2016-11-17T06:50:17Z","timestamp":1479365417000},"page":"1360-1365","source":"Crossref","is-referenced-by-count":3,"title":["Differentiated thyroid cancer in patients with prolactinoma"],"prefix":"10.55730","volume":"46","author":[{"given":"Abbas Ali","family":"TAM","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cafer","family":"KAYA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cevdet","family":"AYDIN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reyhan","family":"ERSOY","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bekir","family":"\u00c7AKIR","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"34691","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp025334"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2006.10.005"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1210\/edrv-17-6-639"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1210\/me.2013-1349"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2867-13-103"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"6. Kedzia C, Lacroix L, Ameur N, Ragot T, Kelly PA, Caillou B, Binart N. Medullary thyroid carcinoma arises in the absence of prolactin signaling. Cancer Res 2005; 6: 8497-8503.","DOI":"10.1158\/0008-5472.CAN-04-3937"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1210\/edrv.19.3.0334"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/S1043-2760(02)00603-3"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-69-6-1225"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-11-0076"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"11. Fernandez I, Touraine P, Goffin V. Prolactin and human tumourogenesis. J. Neuroendocrinol 2010; 22: 771-777.","DOI":"10.1111\/j.1365-2826.2010.02011.x"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1210\/er.2004-0016"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-009-0214-y"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1677\/JOE-10-0069"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1042\/BJ20060870"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1080\/07853890410033892"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/S0026-0495(99)90038-0"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1007\/s12022-006-0009-x"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1007\/BF02234833"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-4-97"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1007\/s00268-012-1505-4"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"22. Gonz\ufffdlez-Lucano LR, Mu\ufffdoz-Valle JF, Ascencio-Cedillo R, Dom\ufffdnguez-Rosales JA, L\ufffdpez-Rinc\ufffdn G, Del Toro-Arreola S, Bueno-Topete M, Daneri-Navarro A, Estrada-Ch\ufffdvez C, Pereira-Su\ufffdrez AL. Increased expression of the prolactin receptor is associated with malignant laryngeal tumors. Exp Ther Med 2012; 3: 603-607.","DOI":"10.3892\/etm.2012.464"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"23. Bhatavdekar JM, Patel DD, Vora HH, Shah NG, Chikhlikar PR, Ghosh N. Prolactin as a local growth promoter in patients with locally advanced tongue cancer: GCRI experience. Head Neck 2000; 22: 257-264.","DOI":"10.1002\/(SICI)1097-0347(200005)22:3<257::AID-HED8>3.0.CO;2-K"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-08-4652"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1111\/cen.12217"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"26. Freeman ME, Kanyicska B, Lerant A, Nagy G. PRL: structure, function, and regulation of secretion. Physiol Rev 2000; 80: 1523-1631.","DOI":"10.1152\/physrev.2000.80.4.1523"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"27. Rui H, Kirken RA, Farrar WL. Activation of receptor-associated tyrosine kinase JAK2 by prolactin. J Biol Chem 1994; 269: 5364-5368.","DOI":"10.1016\/S0021-9258(17)37695-0"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-04-1870"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"29. Galsgaard ED, Rasmussen BB, Folkesson CG, Rasmussen LM, Berchtold MW, Christensen L, Panina S. Re-evaluation of the prolactin receptor expression in human breast cancer. J Endocrinol 2009; 10: 115-128.","DOI":"10.1677\/JOE-08-0479"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"30. Sethi BK, Chanukya GV, Nagesh VS. Prolactin and cancer: has the orphan finally found a home? Indian J Endocrinol Metab 2012; 16: S195-S198.","DOI":"10.4103\/2230-8210.104038"}],"container-title":["TURKISH JOURNAL OF MEDICAL SCIENCES"],"original-title":[],"deposited":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T17:11:01Z","timestamp":1718903461000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.tubitak.gov.tr\/medical\/vol46\/iss5\/14"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":30,"URL":"https:\/\/doi.org\/10.3906\/sag-1501-58","relation":{},"ISSN":["1300-0144","1303-6165"],"issn-type":[{"value":"1300-0144","type":"print"},{"value":"1303-6165","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}